Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyFidelis Care Prior Auth & Coverage Update | OpenPa…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ModifiedFidelis CarePolicy N/A

    Prior Authorization and Coverage Criteria — Fidelis Care Medicaid/CHP/HealthierLife

    Customize your policy alerts

    Sign up for all Fidelis Care policy alerts

    Know when Fidelis Care releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Operational and authorization guidance for Fidelis Care Medicaid/CHP/HealthierLife providers covering inpatient, outpatient, behavioral health, transplant, surgical, and substance use disorder services in New York State. Affects network and non-network providers rendering services to Fidelis Care members.

    Policy Summary
    PayerFidelis Care
    PolicyPrior Authorization and Coverage Criteria — Fidelis Care Medicaid/CHP/HealthierLife
    Policy Code (N/A)N/A
    Change TypeMaterial operational and coverage updates (ABA, TMS, developmental screening, PH/IOP clarification)
    Effective DateOct 1, 2025
    Next Review DateN/A
    Key ActionObtain prior authorization for all non-emergent inpatient admissions and for listed services (e.g., transplants, TMS, behavioral testing, specified outpatient procedures).
    SourceLink
    POLICY UPDATE CHANGES

    Applied Behavior Analysis (ABA) services are included in the Medicaid managed care benefit for members under age 21 and require prior authorization and enrollment of providers in NYS Medicaid.

    First seven days of Intensive Outpatient Treatment and Mental Health Continuing Day Treatment do not require prior authorization; additional days require authorization.

    PROS no longer requires prior authorization effective February 1, 2022.

    Transcranial Magnetic Stimulation (TMS) covered with authorization required for CPT codes 90867-90869 with clinical criteria including adult MDD and failure of medication and psychotherapy.

    Developmental screening CPT 96110 reimbursed without authorization in the first three years of life with specific limits and required diagnosis codes for Medicaid.

    All inpatient admissionsInpatient PA rule
    28 daysOASAS SUD exemption
    14 daysOMH under-18 exemption
    90867-90869TMS PA codes
    3 or 4PH/IOP utilization triggers
    ~120+Appendix I PA codes

    Coverage Criteria and Medical Necessity

    Inpatient admissions

    Covered when authorization obtained and medically necessary:

    Inpatient Admission Authorization: All inpatient admissions require authorization except emergency room services or emergent stabilization; post-stabilization inpatient admissions require authorization.

    All facility admissions are reviewed for medical necessity; prior authorization fax number referenced in policy.

    Inpatient SUD (OASAS) exemption

    Inpatient SUD in-network OASAS-licensed facility coverage rules:

    In-network OASAS Licensed Inpatient SUD: In-network, in-state OASAS-licensed inpatient SUD services are not subject to prior authorization or concurrent utilization review for the first 28 days provided the facility notifies Fidelis Care within two business days and submits the OASAS Appendix A Notification Form and the LOCADTR Medical Necessity Tool.28 days
    Policy Summary
    PayerFidelis Care
    PolicyPrior Authorization and Coverage Criteria — Fidelis Care Medicaid/CHP/HealthierLife
    Policy Code (N/A)N/A
    Change TypeMaterial operational and coverage updates (ABA, TMS, developmental screening, PH/IOP clarification)
    Effective DateOct 1, 2025
    Next Review DateN/A
    Key ActionObtain prior authorization for all non-emergent inpatient admissions and for listed services (e.g., transplants, TMS, behavioral testing, specified outpatient procedures).
    SourceLink
    On This Page
    Coverage Criteria and Medical NecessityRelevant Codes and Code GroupsProvider Actions, Authorization & DocumentationBackground and ScopeDefinitions and Key Terms

    Facility must perform daily clinical review; periodic consultation with Fidelis Care begins on or just prior to Day 14; services may be subject to utilization review after Day 28 or upon discharge.

    OMH inpatient mental health

    OMH-licensed inpatient mental health coverage rules:

    OMH inpatient general rule: Inpatient mental health treatment provided by OMH-licensed hospitals in NYS that participate in the network are not subject to prior authorization, provided the facility notifies Fidelis Care within two business days of admission and initial treatment plan.

    Notification via OMH Two-Day Notification and Initial Treatment Plan form is required; facility must perform daily clinical review and participate in periodic consultation to ensure use of approved clinical review criteria.

    Triggers for utilization review: Utilization review may be conducted for members meeting OMH triggers including current AOT order, AOT expired within 5 years, high utilization (>=3 psychiatric inpatient hospitalizations OR >=4 psychiatric ED visits OR >=3 medical inpatient hospitalizations in prior 12 months), readmission within 30 days, or length of stay exceeding 30 days.30 days for LOS trigger

    Out-of-network inpatient mental health services remain subject to concurrent review throughout the admission.

    OMH inpatient under 18 network exception: For members under 18 admitted to in-network OMH-licensed hospitals, admissions are not subject to prior authorization or concurrent review for the first 14 days provided the facility notifies Fidelis Care within two business days, performs daily clinical review, and participates in periodic consultation.14 days

    Notification fax/email details available in policy.

    Outpatient surgery

    Outpatient surgical/procedural authorization rules:

    Designated outpatient procedures: Specific outpatient surgery and procedure CPT/HCPCS codes listed in the policy require prior authorization when performed in specified places of service; some codes require authorization regardless of place of service. Delegation for certain code groups to third parties (TurningPoint, Evolent/NIA) is noted.

    Refer to code lists in policy for code-level requirements and delegated vendors.

    20610 hyaluronic acid exclusion: CPT 20610 is non-covered when billed with hyaluronic acid HCPCS codes (J7318–J7332 series) and an osteoarthritis of the knee diagnosis (M17 series); in other situations 20610 does not require authorization.

    Exact HCPCS and ICD-10 codes are enumerated in the policy text.

    Behavioral health testing

    Behavioral health testing coverage stance:

    Psychological/Neuropsychological Testing: Testing codes 96116, 96121, 96130-96133, 96136-96139, and 96146 require prior authorization and requests should be submitted using the Psychological/Neuropsychological testing request form.
    Developmental Pediatric Testing and Screening: CPT 96112 and 96113 require authorization. CPT 96110 (developmental screening) does not require authorization (excluding CHP) when performed in the child's first three years of life and must be billed with diagnosis Z13.41 or Z13.42 for Medicaid, with documented scoring of a validated screening tool per AAP/Bright Futures guidance.First three years of life rules apply

    ASD screening reimbursable up to two times beginning at 18 months; global delay screening up to once per year.

    Partial Hospitalization medical necessity

    Partial Hospitalization (PH) mental health treatment for all ages is covered when ALL of the following NYS OMH criteria are met:

    PH Eligibility per NYS OMH: Member is treated by an OMH-licensed program in NYS AND meets at least one of the OMH triggers: currently subject to an AOT court order OR had an AOT order expired within 5 years OR meets high utilization criteria (>=3 psych inpatient hospitalizations OR >=4 psych ED visits OR >=3 medical inpatient hospitalizations in prior 12 months) OR readmission within 30 days OR length of stay exceeds 30 days (concurrent review from Day 31).see thresholds

    Utilization review (admission and concurrent/continued stay) is conducted only for members meeting these criteria; out-of-network facilities are subject to concurrent review throughout admission.

    Intensive Outpatient medical necessity

    Intensive Outpatient (IOP) mental health treatment is covered under the following logic:

    IOP Admission and Concurrent Review: The first seven days of IOP services do not require prior authorization; additional service days require authorization. Continued services beyond initial days are subject to NYS OMH clinical criteria (AOT status, recent high utilization, 30-day readmission, or length of stay >30 days) and utilization review; out-of-network facilities remain subject to concurrent review throughout the admission.first 7 days no auth; see thresholds for utilization triggers

    Authorization required for additional days beyond seven; concurrent review considerations apply from Day 31 for LOS triggers.

    ABA coverage criteria

    Applied Behavior Analysis (ABA) coverage conditions:

    ABA Eligibility: Member is under 21 AND has a DSM-5 diagnosis of autism spectrum disorder or Rett Syndrome AND is referred by an eligible NYS licensed clinician AND services are delivered by a Licensed Behavior Analyst (LBA), Certified Behavior Analyst Assistant (CBAA) under LBA supervision or other authorized providers and the provider is enrolled in the NYS Medicaid Program.age <21

    Prior authorization is required; Fidelis ABA authorization form is provided via policy link.

    TMS coverage criteria

    Transcranial Magnetic Stimulation (TMS) coverage conditions:

    TMS Eligibility: Member is over 18 AND has a confirmed diagnosis of major depressive disorder (MDD) AND TMS is administered using an FDA-cleared device according to FDA-labeled indications AND there is documented failure to respond to multiple medication trials and evidence-based psychotherapy during the current episode of illness.age >18

    Authorization required for CPT codes 90867, 90868, and 90869; requests may be submitted via specified fax/email/phone for Behavioral Health.

    Developmental screening coverage

    Developmental screening coverage in first three years of life:

    96110 Reimbursement Conditions: Developmental screening (CPT 96110) is reimbursed without authorization when performed in the child's first three years of life, the provider documents scoring and objective data from a validated screening tool, and billing uses diagnosis Z13.41 or Z13.42 for Medicaid as applicable. ASD screening may be reimbursed up to two times beginning at 18 months; global developmental delay screening up to once per year.age <=3 years; ASD screening begin 18 months

    Screening should follow AAP/Bright Futures periodicity schedule (9, 18, 30 months for global delay; 18 and 24 months for ASD).

    DXA authorization exceptions

    DXA coverage exceptions and authorization rules:

    DXA no-auth exceptions: Authorization is not required for one DXA (CPT 77080 or 77081) every two years for: (a) women age >65 when billed with diagnosis Z13.820; (b) men age >70 when billed with Z13.820; (c) women age 51–64 when billed every two years with any of the diagnosis codes on the attached list; (d) men age 51–69 when billed every two years with any of the diagnosis codes on the attached list.age-based; 1 per 2 years

    Requests outside these age/diagnosis combinations require prior authorization.

    OB Ultrasound Criteria

    OB ultrasound coverage rules

    OB ultrasound rules: Allow up to the first four OB ultrasounds for a normal pregnancy without authorization; five or more ultrasounds for a normal pregnancy require prior authorization. OB ultrasounds for listed high-risk pregnancy diagnosis codes do not require authorization.>4 ultrasounds

    High-risk pregnancy ICD-10 diagnosis codes are enumerated in the policy.

    DXA Coverage Criteria

    DXA scan coverage without authorization

    DXA no-PA criteria: Authorization not required when: (a) women >65 have one 77080/77081 every 2 years with diagnosis Z13.820; (b) men >70 have one 77080/77081 every 2 years with Z13.820; (c) women 51–64 have one 77080/77081 every 2 years when accompanied by diagnosis codes on the policy list; (d) men 51–69 have one 77080/77081 every 2 years when accompanied by diagnosis codes on the policy list.1 per 2 years

    Requests outside these criteria require authorization.

    Therapeutic Services - Not Covered / PA

    Therapeutic services requiring authorization or not covered

    Not covered for Low Back Pain: For members with a diagnosis of Low Back Pain, the following are not covered: prolotherapy; therapeutic facet joint steroid injections in the lumbar and sacral regions (with or without CT guidance); therapeutic injections of steroids into intervertebral discs; and continuous or intermittent traction.diagnosis = Low Back Pain

    These services are explicitly listed as non-covered in the policy.

    Oncology Pharmacy PA Criteria

    Oncology and pharmacy PA delegation

    Oncology medication PA: Oncology medications and supportive agents require prior authorization from Evolent (except Child Health Plus) before dispensing or administration for Medicaid Managed Care and HARP (medical benefit). Requests to Evolent may be submitted via the vendor web portal or phone as specified in policy.all oncology meds/supportive agents

    Certain request types are excluded from Evolent review as enumerated in policy (e.g., antibiotics, bone marrow/stem cell transplants, CAR-T, inpatient drug requests).

    Diabetes Self-Management Training

    Diabetes Self-Management Training

    DSMT coverage: Members are allowed up to 10 hours (20 units) in a continuous six-month period; services must be provided by certified providers and do not require authorization when billed with codes G0108 and G0109.10 hours/20 units per 6 months

    No prior authorization required for covered DSMT services.

    Asthma Self-Management Training

    Asthma Self-Management Training

    ASMT coverage: Authorization is not required for codes S9441, S9445, S9446 when billed with diagnosis J45x. Newly diagnosed or medically complex members may receive up to 10 hours of ASMT in a continuous six-month period; medically stable members may receive up to 1 hour in a continuous six-month period.10 hours or 1 hour per 6 months

    Group sessions limited to a maximum of eight patients.

    Out-of-state or out-of-network facilities that are not OASAS‑licensed or that are outside Fidelis Care’s provider network must request prior authorization and remain subject to concurrent review for outpatient substance use disorder (SUD) services. In-network, in‑state outpatient SUD services (including office visits, clinic visits, intensive outpatient programs, outpatient rehabilitation, and opioid treatment programs) are exempt from prior authorization and concurrent review only when provided by in‑network OASAS‑licensed facilities and when facility notification requirements are met. Providers with questions should contact Fidelis Care Behavioral Health at 1‑888‑FIDELIS, extension 16072.

    CPT 20610 (arthrocentesis/therapeutic injection; major joint) is explicitly non‑covered when billed together with the listed hyaluronic acid HCPCS products (J7318, J7320, J7321, J7322, J7323, J7324, J7325, J7326, J7327, J7328, J7329, J7331, J7332) for members with a diagnosis of osteoarthritis of the knee (ICD‑10 codes M17 series). In all other situations CPT 20610 does not require prior authorization.

    Core Limited Health Related Services (CLHRS) provided by eligible 29‑I Health Facilities are covered on a per‑diem basis and include nursing, skill building LBHP, treatment planning and discharge planning, clinical consultation/supervision, and VFCA liaison/administration. No utilization review will be conducted for these CLHRS services when delivered by an eligible 29‑I Health Facility in accordance with the 29‑I Billing Guidance.

    For members with a diagnosis of Low Back Pain, the policy lists several therapeutic services as not covered: prolotherapy; therapeutic facet joint steroid injections in the lumbar and sacral regions (with or without CT fluoroscopic guidance); therapeutic steroid injections into intervertebral discs; and continuous or intermittent traction. These therapies should not be provided or billed for Low Back Pain under the medical benefit.

    Certain request types are excluded from Evolent (Oncology) review and should not be submitted to Evolent. Exclusions include: antibiotics; bone marrow/stem cell transplants and CAR‑T cell therapy; specified individual products (for example, Cablivi); controlled substances; equipment requests; genetic laboratory testing and lab services; hemophilia drugs and immune globulins; inpatient drug requests; iron preparations; pain medications; radiopharmaceuticals; surgeries/surgical procedures; and sickle cell diagnoses. These requests must be handled outside the Evolent oncology review workflow per the policy.

    Authorization is generally required for the J‑/HCPCS codes in Appendix I; however, an explicit exception applies to ophthalmic uses of bevacizumab. The policy states that authorization is not required for ophthalmic indications of bevacizumab (J9035 family). Providers should follow Appendix I mapping instructions for other J‑/HCPCS codes and note member‑type specific authorization footnotes where present.

    Many procedures completed within a 24‑hour period will not be approved as inpatient level of care. These same procedures, when billed as outpatient and performed within the Fidelis Care network, generally do not require authorization. Providers should not assume inpatient status for short‑duration (≤24 hours) procedures; confirm place‑of‑service billing and consult the authorization grid for exceptions to avoid inpatient denials.

    Selected gastroenterology procedures require prior authorization when performed in place of service 19 or 22 (off‑campus outpatient facility / off‑campus outpatient hospital) if an office‑based setting or ambulatory surgery center (ASC) is available to provide the service. The specified CPTs include 43235, 43239, 43248, 45378, 45380, 45384, 45385, 46255, 46260, and 46270; these procedures do not require authorization when performed in POS 11 (office) or POS 24 (ASC). Authorization is required for 43290 in any place of service.

    Therapeutic facet joint steroid injections in the lumbar and sacral regions are specifically listed as not covered for members with a diagnosis of Low Back Pain. This represents an explicit not‑medically‑necessary (NMN) condition for those CPT/HCPCS services when the clinical indication is Low Back Pain.

    All solid organ and bone marrow / tissue transplant procedures require prior authorization at the time of the transplant evaluation. The policy lists the transplant‑related CPT codes covered by this requirement (examples include 32850–32856; 33930–33945; 38204–38215; 38230–38242; 44133–44136; 47133–47147; 48160; 48550–48556; 50300–50380; 50547; 65710–65757). Providers must obtain authorization before proceeding with transplant evaluations and services.

    Relevant Codes and Code Groups

    Transplant-related CPT codesCPTCovered
    38243Bone marrow transplant, unrelated donor (add-on)
    Outpatient surgery and dermatologic CPT/HCPCS codes requiring authorizationmixedCovered
    10040Incision and drainage of pilonidal cyst; simple
    11100Biopsy of single lesion, skin
    15011Excision of benign lesion of trunk, arms or legs; excised diameter 0.5 cm or less
    15012... diameter 0.6 to 1.0 cm
    11300Shaving of epidermal or dermal lesion
    11400Excision of benign lesion including margins
    11730Avulsion of nail plate, partial or complete, simple
    11200Removal of skin tags, up to 15
    A2030Medicated dressing, each
    A2031Disposable electrode
    1–10 of 13
    1/2
    Vascular procedure CPT codesCPTCovered
    36465Laser ablation of incompetent vein
    37241Transcatheter occlusion or embolization
    37243Transcatheter therapy, peripheral artery
    37718Ligation of varicose vein
    CAR-T therapy and related codesmixedCovered
    Q2058CAR-T product code (example)
    38225Autologous hematopoietic progenitor cell collection for transplantation
    38226Processing for hematopoietic progenitor cells
    38227Collection, allogeneic
    38228Transplant infusion
    Behavioral health testing CPT codesCPTCovered
    96116Neurobehavioral status exam
    96121Neurobehavioral status exam by physician
    96130Psychological testing evaluation services by psychologist
    96131Psychological testing evaluation by technician
    96132Neuropsychological testing evaluation services
    96133Neuropsych testing by technician
    96136Psychological testing admin and scoring
    96137Psych test admin by technician
    96138Psychological testing administration complex
    96139Psychological testing admin by tech complex
    1–10 of 11
    1/2
    Psychological/Neuropsychological Testing CPTsCPTCovered
    96116Neurobehavioral status exam
    96130Psychological testing evaluation services
    96136Psychological or neuropsych testing admin/scoring
    96146Psych testing interpretation report
    96121Physician neurobehavioral status exam
    96131Psych testing by technician
    96132Neuropsych testing eval
    96133Neuropsych testing by tech
    96137Psych test admin by technician
    96138Psych testing complex
    1–10 of 11
    1/2
    Developmental Pediatric TestingCPT
    96112Developmental test, limited
    96113Developmental test, extended
    96110Developmental screening, established patient (no auth required in many cases)
    Behavioral Health program / CORE / CFTSS / HCBS service codesmixedCovered
    H2017Psychosocial rehabilitation (CORE)
    H0036Community psychiatric support and treatment (CPST)
    H0038Peer supports / empowerment services
    H2012Partial hospitalization / Continuing Day Treatment
    T2017Habilitation and Residential Support Services
    T2015Pre-Vocational Services
    A0160Provider travel supplement
    TMS CPT codesCPTCovered
    90867TMS with neuronavigation initial
    90868TMS daily
    90869TMS subsequent evaluation
    Diagnostic and Gastroenterology codes requiring PAmixedCovered
    43290Esophagogastroduodenoscopy with single/double balloon
    45384Colonoscopy, biopsy or polypectomy complex
    91110Wireless capsule endoscopy, esophagus
    91111Wireless capsule endoscopy, small intestine
    46270Local excision of lesion of rectum
    45380Colonoscopy, removal of tumor
    43235Esophagoscopy with dilation
    45378Colonoscopy with removal of foreign body
    42975Laryngoplasty
    DME and supply HCPCS codes (authorization as noted)HCPCSCovered
    T2101Donor Breast Milk (authorization required when outpatient)
    A4335Surgical supply
    A4554Oxygen tubing
    T4521Ostomy supply
    T4522Ostomy supply
    A7010CPAP mask (example)
    DXA and TBS scan codesCPT
    77080Dual-energy X-ray absorptiometry (DXA), axial skeleton
    77081DXA, appendicular skeleton
    77089TBS software (trabecular bone score)
    77090TBS technical component
    77091TBS professional component
    77092TBS interpretation
    CORE, CFTSS, HCBS service codes (behavioral health)mixedCovered
    H2014Family support and training
    H2011Other licensed practitioner services
    H2001Crisis intervention
    S9484Partial hospitalization adjunct code
    S9485Crisis service adjunct
    H0035Partial hospitalization, substance abuse
    H0040Assertive Community Treatment (ACT)
    OB pregnancy diagnosis / ultrasound threshold reference codesICD-10
    Z32.01Pregnancy test positive
    Z34.00Encounter for supervision of normal first pregnancy
    Z33.1Pregnancy with uterine scar from previous surgery
    O09.00Supervision of high-risk pregnancy
    O36.80X0Pregnancy complication, fetus not specified
    Z34.9Encounter for supervision of normal pregnancy, unspecified
    DXA CodesCPTCovered
    77080DXA scan, axial skeleton
    77081DXA scan, appendicular skeleton
    Therapeutic service CPT codesCPTCovered
    20526Injection, tendon sheath or ligament
    20550Injection of tendon sheath
    62263Injection, epidural
    64600Destruction of nerve
    64553Sacral neuromodulation testing
    92066Vision therapy, per session
    95919Neurostimulator procedure
    Transportation HCPCS codes requiring authorizationHCPCSCovered
    A0430Ambulance, basic life support, non-emergency
    A0431Ambulance, basic life support, emergency
    A0435Ground mileage
    A0436Ground non-emergency transport, advanced life support
    Appendix I — selected HCPCS/J codes requiring prior authorizationHCPCSCovered
    J0887Epoetin beta, ESRD (Mircera) mapping noted in appendix
    J0888Epoetin beta, non-ESRD
    J0889Daprodustat oral, ESRD mapping
    J0897Denosumab (Prolia, Xgeva) mapping
    J0901Vadadustat mapping (Vafseo)
    J0911Taurolidine/heparin mapping
    J1072Testosterone cypionate injection mapping
    J1075Oritavancin mapping
    J1096Dextenza insert mapping
    J1201Cetirizine (Quzyttir) mapping
    1–10 of 61
    1/7
    Codes Requiring Prior Authorization — additional examplesHCPCSCovered
    J2350Immune globulin mapping (example from appendix)
    J2351Immune globulin mapping
    J2353IVIG mapping
    J2356Immune glob over 10cc mapping
    J2323Immune glob mapping (C9145 group)
    J2326Immune glob mapping (J0879 group)
    J2327Immune glob mapping (J0887 group)
    J2329Immune glob mapping (J0888 group)
    J2358IVIG mapping
    J2370IVIG mapping
    1–10 of 12
    1/2

    Provider Actions, Authorization & Documentation

    Prior Authorization

    Inpatient authorizations

    All inpatient admissions require prior authorization. Emergency room services and emergency stabilization do not require authorization, but post-stabilization services and any inpatient admissions following ED care do require authorization. Facilities must notify Fidelis Care within required timelines and failure to obtain authorization may result in denial of coverage.

    • New fax number for Inpatient ER: 833-663-1602 (formerly 347-868-6411)
    Prior Authorization

    Transplant authorization

    Authorization is required at the time of transplant evaluation for all solid organ and bone marrow/tissue transplants. Lack of authorization at transplant evaluation may lead to claim denial.

    Prior Authorization

    Outpatient surgery preauthorization

    Multiple outpatient surgery and procedure CPT/HCPCS codes require prior authorization; some authorization responsibilities are delegated to partner vendors (e.g., TurningPoint, Evolent) as noted. For CPT codes delegated to TurningPoint or Evolent, requests should be submitted to the delegated vendor per their instructions.

    • Selected categories requiring authorization include bariatric surgery, blepharoplasty, breast reconstruction/mammoplasty, skin surgery (selected CPTs when performed as ambulatory surgery POS 24), eyelid & ocular surgery, abdominoplasty/lipectomy/panniculectomy, facial cosmetic/septoplasty/rhinoplasty, vascular procedures, spine surgery, CAR-T therapy, hernia repair, and others listed in Section III.
    • For CPT codes delegated to TurningPoint, submit prior authorization to TurningPoint Healthcare Solutions, LLC.
    • For CPT codes delegated to Evolent (NIA), submit per Evolent instructions.
    Prior Authorization

    Partial Hospitalization authorization

    Partial Hospitalization (PH) services require utilization review for admission and concurrent/continued stay. PH provided by OMH-licensed programs in NY are reviewed only when clinical criteria per NYS OMH Best Practice Manual are met. The first 7 service days do not apply here (see Continuing Day Treatment note) — ongoing concurrent review applies as described and services not meeting OMH criteria may be denied.

    • Rate codes: 4349–4363 and revenue codes 912, 913. HCPCS: H0035 and S9484.
    • Clinical criteria triggers include AOT court orders, high utilization (3+ psych inpatient hospitalizations or 4+ psych ED visits in prior 12 months, or 3+ medical inpatient hospitalizations), readmission within 30 days, or length of stay >30 days (concurrent review from Day 31).
    • Requests for members under 21: email chmmc@fideliscare.org or fax 833-663-1604; phone 1-888-FIDELIS and follow Children's Medicaid prompts.
    Prior Authorization

    Outpatient diagnostic prior authorization

    Outpatient diagnostic testing and selected gastroenterology procedures require prior authorization. Some genetic tests and radiology services are excluded or have specific rules; wireless capsule endoscopy and wireless motility capsule require authorization. Gastroenterology procedures listed require authorization when performed in POS 19 or 22 if an office or ASC is available; certain codes (e.g., 43290) require authorization in any POS.

    • Sleep studies (including home sleep studies) require authorization.
    • Wireless Capsule Endoscopy: CPT 91110, 91111; Wireless Motility Capsule: 91112, 91113 require authorization.
    • Gastroenterology: 43235, 43239, 43248, 45378, 45380, 45384, 45385, 46255, 46260, 46270 require authorization in POS 19/22 when office/ASC available; 43290 requires authorization in any POS.
    • Breast cancer/genetic testing: authorization not required for CPT 81244, 81329, 81331, 81336, 81420; CPT 81220 has lifetime limit of 1; CPT 81329 and 81336 combined limit of 1 per lifetime.
    Prior Authorization

    Therapy services authorization

    Home and outpatient therapy services (PT, OT, ST) after the initial evaluation require prior authorization through Evolent (NIA). Inpatient therapy authorization requests must be faxed to the dedicated inpatient therapy fax. Non-therapy providers should request authorizations through Fidelis Care.

    • Home & Outpatient PT/OT/ST (after initial evaluation) require PA through Evolent (NIA). Home therapy initial evaluation requires authorization.
    • CPT 92610 and 92611 do not require prior authorization.
    • For outpatient setting, authorization to Evolent (NIA) must be sent within 1 business day when billing codes other than initial evaluation codes.
    • Inpatient therapy PA fax: 833-663-1611 (formerly 716-803-8307).
    • Requests for inpatient therapy should be submitted to Fidelis; non-therapy providers (MD/DO/DPM) must request authorization directly through Fidelis Care.
    Prior Authorization

    DME and supply authorization

    Durable medical equipment (DME) and specific medical supplies may require authorization — rules differ by product, member line of business, and place of service. Refer to the Medicaid DME Program Manual and the Fidelis lists for codes that require authorization. Certain supply codes for MLTC require authorization.

    • DME coverage guidance: https://www.emedny.org/ProviderManuals/DME/index.aspx
    • Effective 4/1/23, specific DME supplies billed by physicians (POS 12/14) for Medicaid/HARP were transitioned to NYS FFS (NYRx) — see Medical Supply Procedure Codes & Coverage Guidelines.
    • MLTC-only supply codes requiring authorization: A4335, A4554, T4521–T4524, T4529, T4530, T4533, T4535, T4537, T4539, T4540, T4543.
    • T2101 (Donor Breast Milk) requires authorization only in outpatient setting.
    Prior Authorization

    Therapeutic Services PA

    Prior authorization is required for a number of therapeutic services and procedures, including phototherapy, hyperbaric oxygen, selected pain management/interventional pain procedures, topical oxygen, radiation therapy (delegated to Evolent), ambulatory continuous glucose monitoring, RFA of uterine fibroids, bronchial thermoplasty, and other listed therapies.

    • Phototherapy CPTs: 96567, 96573, 96574, 96900, 96910, 96912, 96913, 96920–96922.
    • Pain management and interventional pain CPTs include a wide range (e.g., 20526, 20550–20553, 27096, 62263–62290, 62320–62327, 64400–64530, 64553–64595, 64600–64640, 64618–64640); select interventional pain CPTs: 63650, 63655, 63661–63664, 63685, 63688 and specified HCPCS (C1778, C1787, C1883, C1897).
    • Topical oxygen requires prior authorization.
    • Ambulatory CGM: 95249 requires prior authorization.
    • Radiofrequency ablation of uterine fibroids: 58674 requires prior authorization.
    • Bronchial Thermoplasty: 31660, 31661 require prior authorization.
    • Radiation Therapy prior authorization delegated to Evolent (NIA).
    Prior Authorization

    TBS Scan PA

    Trabecular Bone Score (TBS) scans require prior authorization for the listed CPT codes.

    • TBS scan CPTs: 77089, 77090, 77091, 77092 require authorization.
    Denial Risk

    Partial Hospitalization denial triggers

    Partial Hospitalization and Intensive Outpatient services have specific denial triggers when authorization or clinical criteria are not met. Partial hospitalization services not meeting NYS OMH criteria may be denied; intensive outpatient days beyond the first seven require authorization and extended stays or days without authorization may lead to denial.

    • PH denial triggers: services not meeting NYS OMH Best Practice Manual criteria (see PH callout) may be denied.
    • IOP: No prior authorization needed for first seven days; additional days require authorization — failure to obtain authorization for additional days may result in denial.
    • All out-of-network PH and IOP services are subject to concurrent review throughout the admission.
    Denial Risk

    TMS denial risk

    TMS requests must document prior trials of medication and evidence-based psychotherapy during the current episode of illness and meet FDA-labeled indications (e.g., confirmed diagnosis of Major Depressive Disorder). Requests lacking documentation of medication and psychotherapy failure risk denial.

    • Covered when using an FDA-cleared device and meeting clinical criteria including failure to respond to multiple medication trials and psychotherapy during the current episode.
    • Authorization required for CPT codes 90867, 90868, 90869.
    • Submit requests via email qhcmbh@fideliscare.org, fax 833-561-0098, or call 1-888-FIDELIS and follow Behavioral Health prompts (ext. 16072).
    Step Therapy

    TMS step therapy requirement

    TMS authorization requires documented trials of prior medications and psychotherapy (step therapy requirement) before authorization will be granted.

    • Members over 18 eligible when TMS administered with FDA-cleared device and documented failure of multiple medication trials and evidence-based psychotherapy during the current episode of illness.
    Prior Authorization

    Prior authorization required for listed codes

    Prior authorization is required for drugs and biologics listed in Appendix I and for J-/HCPCS codes enumerated in Appendix I prior to billing or administration. Oncology medications and supportive agents are reviewed by Evolent; pharmacy PA submissions to Fidelis Pharmacy Team must use the specified e-fax.

    • Appendix I lists HCPCS/J-codes that require PA prior to service or administration; failure to obtain PA may result in claim denial.
    • Oncology meds/supportive agents: submit to Evolent via their web portal or phone per Section IV(B).
    • Submit PA requests to Fidelis Pharmacy Team via e-fax: 1-844-235-5090 for Appendix I items not under Evolent review.
    • Authorization not required for ophthalmic bevacizumab (J9035 family) for ophthalmic indications (see Appendix notes).
    Documentation Required

    Developmental screening documentation

    Developmental screening (CPT 96110) is reimbursed under specific conditions and must include scoring and documentation using validated instruments. For Medicaid, 96110 must be billed with diagnosis Z13.41 or Z13.42 and follow the Bright Futures/AAP periodicity schedule; documentation must record objective scores and any delays.

    • CPT 96110: No authorization required (excluding CHP). Reimbursed in the first three years of life and may be billed in addition to an E/M visit effective 4/1/2022.
    • ASD screening may be reimbursed up to twice in the first three years (beginning at 18 months); global developmental delay screening reimbursed up to once per year in first three years.
    • For Medicaid, bill CPT 96110 with Z13.41 (autism screen) or Z13.42 (screening for global developmental delays).
    • Providers must score and document objective data from standardized, validated screening tools and record measurable parameters.
    Documentation Required

    Respite services documentation

    Short-term planned and crisis respite services have annual limits; respite beyond those limits requires medical necessity documentation including LPHA attestation and NYS DOH Children's HCBS Authorization and Care Manager Notification form. Submit required forms prior to rendering service to avoid claims disruption.

    • Short-term Planned and Crisis Respite: annual limit of 14 days (1,344 15-minute units). Beyond this requires medical necessity.
    • Required documentation: LPHA Attestation and NYS DOH Children's HCBS Authorization & Care Manager Notification Form.
    • Submit by email to SM_Childrens_HCBS@fideliscare.org or fax 833-663-1604, or call 1-888-FIDELIS and follow Children's Medicaid prompts.
    • Providers should not wait until initial authorization expires before requesting concurrent review; submit before end of existing authorization.
    Prior Authorization

    Inpatient therapy PA fax and routing

    For inpatient therapy prior authorization requests, use the dedicated fax number and follow routing guidance to ensure timely processing. Non-therapy providers must request inpatient therapy authorizations through Fidelis Care.

    • Inpatient therapy PA fax: 833-663-1611 (formerly 716-803-8307).
    • For other inpatient prior authorization questions, contact Fidelis Care per standard UM channels.
    Note

    Fidelis Care will utilize quality and case management oversight

    Fidelis Care will utilize quality and case management oversight initiatives to manage outlier behavioral health member needs. Providers can reference Fidelis Care communications on the Behavioral Health Outliers Management Program for additional details.

    • Effective 01/01/2020 Fidelis removed authorization for many outpatient SUD services in-network/in-state; for outlier management, Fidelis will use quality and case management oversight and may require authorization for out-of-state or out-of-network services.
    Note

    Member-specific authorization notes

    Some codes in Appendix I contain member-type or line-of-business specific authorization notes (for example, CHP exceptions or authorization requirements that differ by NYM/HARP/CHP). Review Appendix I entries and section notes carefully before submission.

    • Examples: authorization may be required for CHP members but not for NYM or HARP for select drugs; ophthalmic bevacizumab (J9035 family) is noted as not requiring authorization for ophthalmic indications.
    • Maximum unit edits apply to all HCPCS codes regardless of authorization status.

    Background and Scope

    This policy provides administrative and utilization management guidance across a broad range of services and settings, including inpatient admissions, inpatient behavioral health (OMH/OASAS), outpatient procedures, surgical services, diagnostic testing, therapeutic services, transplant evaluations, and pharmacy/oncology review. Key operational rules include: all non‑emergent inpatient admissions require prior authorization (emergency stabilization is exempt); in‑network OASAS inpatient SUD facilities are exempt from concurrent review for the first 28 days when notification and required forms are submitted; OMH‑licensed inpatient admissions for members under 18 are exempt from concurrent review for the first 14 days with timely notification; many outpatient procedures and specific J/HCPCS codes require prior authorization or delegated review by vendor partners (Evolent/TurningPoint); and delegated oncology/pharmacy review processes and Appendix I coding mappings govern prior authorization for many specialty drugs.

    Definitions and Key Terms

    LOCADTR — Medical Necessity Tool (OASAS inpatient SUD)
    LOCADTR — definition and useLOCADTR is the Medical Necessity Tool used for OASAS inpatient SUD clinical review, notification, and concurrent/utilization review processing (facilities must submit LOCADTR and consult with Fidelis Care starting just prior to Day 14)
    Submission optionsFacility may fax or email the LOCADTR and OASAS Appendix A to fax 833‑663‑1608 or LOCADTR@fideliscare.org
    Role in reviewLOCADTR is used for retrospective and concurrent review after the exemption period and to support discharge planning
    OMH Two‑Day Notification & Initial Treatment Plan
    OMH Two‑Day Notification and Initial Treatment Plan — purposeForm developed by OMH that inpatient mental health facilities must submit to notify Fidelis Care of admission and initial treatment plan within two business days to preserve the 14‑day concurrent‑review exemption for in‑network under‑18 admissions
    Submission channelsSubmit by fax to 833‑561‑0094 or email Mental_Health_Admission@fideliscare.org
    Related facility obligationsFacility must perform daily clinical review and participate in periodic consultation with Fidelis Care
    ABA — Definition, providers, and PA
    ABA — service definition and eligible providersApplied Behavior Analysis (ABA) are behavioral intervention services for members under 21 with ASD or Rett Syndrome provided by Licensed Behavior Analysts (LBA), Certified Behavior Analyst Assistants (CBAA) under LBA supervision, or other individuals specified under NYS law; providers must be enrolled in NYS Medicaid
    Referral requirementMember must be referred by an eligible NYS licensed clinician (physician, psychiatrist, psychologist, psychiatric nurse practitioner, pediatric NP, or PA)
    Prior authorization and formPrior authorization is required; use the Fidelis ABA authorization request form available on the Fidelis website
    AOT — court‑ordered treatment as a utilization‑review trigger
    AOT as utilization‑review triggerAssisted Outpatient Treatment (AOT) — current AOT order or AOT expired within past 5 years — is a named trigger for utilization review eligibility for PH and IOP services
    ApplicationAOT status is used alongside high‑utilization and readmission/length‑of‑stay criteria to determine need for utilization review
    Source guidanceNYS OMH Best Practice Manual criteria referenced in policy for PH/IOP utilization review triggers
    Normal pregnancy OB ultrasound threshold (definition)
    Normal pregnancy OB ultrasound thresholdUp to 4 OB ultrasounds without prior authorization; 5 or more ultrasounds for a normal pregnancy require prior authorization
    High‑risk pregnancy carve‑outOB ultrasounds for enumerated high‑risk pregnancy ICD‑10 codes do not require authorization
    Relevant diagnosis codesNormal pregnancy diagnosis codes include Z32.01, Z33.1, Z34.00‑Z34.03, Z34.80‑Z34.83, Z34.9‑Z34.93 (see policy list)
    DXA coverage exceptions — age and diagnosis rules
    DXA coverage exceptions — age/diagnosis combosAuthorization not required for one DXA (77080/77081) every 2 years for: women >65 or men >70 with diagnosis Z13.820; and for women 51–64 and men 51–69 when accompanied by any diagnosis code on the attached list
    Frequency allowedOne 77080 or 77081 every two years for qualifying groups
    Other requestsDXA requests outside these age/diagnosis combos require prior authorization
    Appendix product mapping — numbered slots (1–5)
    Code‑to‑product mapping format (1–5) — descriptionAppendix I displays each HCPCS/J code with numbered product positions 1–5; each numbered slot identifies the specific product or mapped code associated with that line item for PA processing (e.g., J7637, 1 = dexamethasone inh.; 2 = J9056; 3 = bendamustine, etc.)
    How to interpret slotsUse the numbered entries to determine which exact product or J‑code the PA applies to for that HCPCS/J line item
    Appendix examplesMultiple examples (e.g., entries for J7165, J7637, J7677) in Appendix I illustrate the 1–5 mapping structure